Form 4: Genprex Officer Mark Berger Reports Share Disposal to Cover Tax Obligations

Chief Medical Officer Mark Berger disposed of 585 shares of Genprex stock on February 18, 2025, to cover tax obligations related to vesting Restricted Stock Units.

Summary

• On February 18, 2025, Mark Berger, Chief Medical Officer of Genprex, Inc., disposed of 585 shares of common stock.
• The shares were sold at a price of $0.41 per share.
• This transaction was to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs) previously granted under the company's 2018 Equity Incentive Plan.
• Following the transaction, Berger directly owns 22,471 shares of Genprex common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider transaction. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of regulatory compliance for company insiders, providing transparency into their transactions in the company's stock. This transaction is a common occurrence where shares are sold to cover tax obligations associated with vesting equity.

Key Dates

Keywords

Form 4, Genprex, Mark Berger, insider trading, GNPX, Chief Medical Officer, Restricted Stock Units, tax withholding, equity incentive plan